Y. Nagai

发表

Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp.

Huqun, Tomoaki Tanaka, Kunihiko Kobayashi, 2005, Cancer research.

Real‐world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive‐disease small‐cell lung cancer

K. Kaira, H. Kagamu, Y. Umeda, 2022, Cancer medicine.

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer

K. Kaira, H. Kagamu, K. Kanazawa, 2022, Investigational New Drugs.

Phase II study of nimustine hydrochloride (ACNU) plus paclitaxel for refractory small cell lung cancer.

A. Gemma, Kunihiko Kobayashi, K. Isobe, 2009, Lung cancer.

Distinct Benefit of Overall Survival between Patients with Non-Small-Cell Lung Cancer Harboring EGFR Exon 19 Deletion and Exon 21 L858R Substitution

K. Hagiwara, Rumi Kawamura, Y. Iwai, 2017, Chemotherapy.

Phase II study of gefitinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) gene mutations detected by PNA-LNA PCR clamp.

K. Hagiwara, H. Miyazawa, A. Sutani, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Administration of crizotinib through gastrostoma resolves esophageal occlusion caused by lymph node metastasis of squamous cell lung cancer with ROS1 fusion gene: a case report

K. Tabata, D. Matsubara, K. Hagiwara, 2019, Annals of Cancer Research and Therapy.

Gefitinib for non-small-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp

K. Hagiwara, M. Kanazawa, H. Miyazawa, 2006, British Journal of Cancer.

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer

K. Kaira, H. Kagamu, K. Kanazawa, 2022, Investigational New Drugs.

Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis.

Huqun, S. Abe, Y. Inoue, 2007, American journal of respiratory and critical care medicine.

Paraneoplastic neurological syndrome presenting as difficulty in mouth opening in a patient with small cell lung cancer

K. Uematsu, K. Nomura, R. Ono, 2012, International Cancer Conference Journal.

Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival

K. Kaira, H. Kagamu, K. Kanazawa, 2022, Thoracic cancer.

Herpes zoster in patients with lung cancer treated with PD-1/PD-L1 antibodies.

S. Nakazawa, K. Hagiwara, H. Ohta, 2022, Immunotherapy.

Severe upper gastrointestinal disorders in pembrolizumab‐treated non‐small cell lung cancer patient

K. Hagiwara, M. Sata, Y. Nagai, 2018, Respirology case reports.

Pulmonary mucoepidermoid carcinoma arising in a patient with Kartagener syndrome

Y. Ishikawa, K. Hagiwara, H. Tsubochi, 2020, BMC Pulmonary Medicine.

Advanced Lung Adenocarcinoma with Nivolumab-associated Dermatomyositis

K. Hagiwara, H. Yabe, T. Demitsu, 2018, Internal medicine.

A Case of Advanced Lung Adenocarcinoma with Nvolumab-associated Dermatomyositis

K. Hagiwara, H. Yabe, T. Demitsu, 2018 .

A young immunocompetent patient with spontaneous Aspergillus empyema who developed severe eosinophilia

H. Ohta, Kentaro Minegishi, S. Koyama, 2017, Respiratory medicine case reports.

Frequency of and variables associated with the EGFR mutation and its subtypes

A. Gemma, K. Uematsu, Tomoaki Tanaka, 2010, International journal of cancer.

Highly sensitive detection of driver mutations from cytological samples and cfDNA in lung cancer

M. Bando, K. Hagiwara, N. Hizawa, 2021, Cancer medicine.

A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer

Kunihiko Kobayashi, M. Tsuchida, H. Miyazawa, 2017, PloS one.

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer

K. Kaira, H. Kagamu, Y. Umeda, 2023, Frontiers in Oncology.

Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation

K. Aoshiba, Hiroyuki Nakamura, Y. Iwai, 2019, PloS one.

Successful treatment of carcinomatous meningitis with erlotinib and whole brain radiotherapy

T. Okano, Kunihiko Kobayashi, H. Sakaguchi, 2012 .

Thrombocytopenia due to bone marrow metastasis of small cell lung cancer that was stabilized by chemotherapy

K. Hagiwara, H. Ohta, S. Koyama, 2019, Annals of Cancer Research and Therapy.

Bicarbonate Attenuates Irinotecan-Induced Cytotoxicity through Regulation of Both Extracellular and Intracellular pHs in Intestine Cell Line

T. Miyazaki, Y. Matsuzaki, Kunihiko Kobayashi, 2013 .

Early‐stage diffuse panbronchiolitis in a young patient confirmed by video‐assisted lung biopsy: A case report

Y. Kawabata, Rumi Kawamura, Y. Iwai, 2017, Journal of general and family medicine.

Rapid Progression of Lung Cancer Following Emergency Caesarean Section Led to Postpartum Acute Respiratory Failure

K. Takagi, Akira Ishii, T. Fukuchi, 2018, Internal medicine.

Reliability of the peptide nucleic acid‐locked nucleic acid polymerase chain reaction clamp‐based test for epidermal growth factor receptor mutations integrated into the clinical practice for non‐small cell lung cancers

Tomoaki Tanaka, Kunihiko Kobayashi, M. Kanazawa, 2007, Cancer science.

Dramatic response to alectinib in a patient with ALK‐rearranged squamous cell lung cancer

H. Ohta, Y. Mizushina, Y. Nagai, 2021, Thoracic cancer.

Peptide nucleic acid–locked nucleic acid polymerase chain reaction clamp‐based detection test for gefitinib‐refractory T790M epidermal growth factor receptor mutation

Tomoaki Tanaka, S. Takenoshita, Kunihiko Kobayashi, 2008, Cancer science.

Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trial

N. Sunaga, Kunihiko Kobayashi, Satoshi Watanabe, 2023, Cancer science.

Using the neutrophil‐to‐lymphocyte ratio to predict the outcome of individuals with nonsquamous non‐small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed

K. Kaira, H. Kagamu, Y. Umeda, 2023, Thoracic cancer.

Effectiveness of nanoparticle albumin-bound paclitaxel plus carboplatin in non-small lung cancer patients with malignant pleural effusion.

K. Aoshiba, Y. Watanabe, Y. Iwai, 2018, Neoplasma.

Successful alectinib treatment for a mechanically ventilated patient with ALK-positive non-small cell lung cancer

K. Hagiwara, Rumi Kawamura, Y. Iwai, 2016 .

Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel.

K. Kaira, H. Kagamu, Y. Umeda, 2023, Oncology.